Limfoma Burkitt Dokter Terbaik di Israel - TOP-20 dokter

Dr. Ram Ron menangani limfoma Burkitt di Sourasky Medical Center (Ichilov), salah satu rumah sakit terbesar dan tercanggih di Israel.

• Lebih dari 25 tahun pengalaman dalam onkologi medis
• Memiliki fellowship dari pusat internasional terkemuka untuk kedokteran reproduksi
• Menangani dengan berbagai prosedur termasuk inseminasi intrauterin
• Menempuh pendidikan di University of Mysore di India

Melakukan beberapa ratus transplantasi sel punca – pengobatan utama untuk limfoma agresif. Dr. Ram adalah ahli hematologi-onkologi bersertifikasi triple board yang bertugas di Rumah Sakit Ichilov.

• Lebih dari 30 artikel yang dipublikasikan dan satu bab buku teks tentang kanker darah
• Menyelesaikan pelatihan fellowship di New York Medical College dalam bidang hematologi dan onkologi
• Memiliki sertifikasi dewan dalam penyakit dalam, hematologi, dan onkologi medis

Kepala Onkohematologi Anak di Rumah Sakit Anak Dana Dwek – Dr. El Hasid spesialis dalam transplantasi sumsum tulang dan darah tali pusat untuk anak-anak.

• Melakukan 300+ prosedur transplantasi
• Menerbitkan 50+ makalah penelitian di bidang onkologi anak
• Menjadi anggota American Association for Hematology
• Menjalani pelatihan di Rumah Sakit City of Hope di Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira berspesialisasi dalam Transplantasi Sumsum Tulang di Sourasky Medical Center (Ichilov), dengan pengalaman luas dalam mengobati kanker darah.

• Lulus dari Fakultas Kedokteran Hebrew University
• Spesialisasi dalam penyakit dalam di Hadassah Medical Center
• Dokter senior dalam Transplantasi Sumsum Tulang di Hadassah

Dr. Dror Levin spesialis dalam hematologi onkologi pediatrik, dengan fokus pada limfoma Burkitt di Sourasky Medical Center di Tel Aviv.

• Direktur departemen hematologi onkologi anak di Sourasky Medical Center
• Spesialisasi dalam hematologi dan onkologi pediatrik di Schneider Children's Medical Center
• Anggota Masyarakat Hematologi Onkologi Pediatrik Israel (ISPHO)
• Mempelajari onkologi tulang dan jaringan lunak di Rizzoli Orthopaedic Institute di Italia

Dr. Fredi Aviv memiliki pengalaman lebih dari 30 tahun dalam mengobati kanker darah di Sourasky Medical Center yang terkemuka di Tel Aviv.

• 31 tahun berdedikasi pada onkohematologi
• Spesialisasi dalam kanker darah agresif
• Praktik di Sourasky Medical Center yang ternama
• Keahlian dalam terapi medis dan biologis terbaru

Seorang ahli hematologi terkemuka yang diakui oleh American Society of Hematology, Dr. Yair merawat pasien di Tel Aviv Sourasky Medical Center.

• Menjalani residensi spesialis hematologi di Tel Aviv Medical Center
• Menjadi pemenang berbagai hibah penelitian dan penghargaan untuk keunggulan klinis
• Menjadi anggota aktif di Asosiasi Hematologi Israel dan Amerika
• Fokus pada penelitian leukemia, termasuk bentuk limfositik

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Spesialis dalam pengobatan limfoma di Rambam Medical Center.

• Berfokus pada hematologi dengan pengalaman luas dalam kasus limfoma
• Bekerja di pusat medis terkemuka yang dikenal dengan perawatan onkologi
• Berdedikasi untuk menyediakan rencana perawatan yang disesuaikan bagi pasien

Profesor Zila Zuckerman adalah spesialis Hematologi dan Transplantologi yang berfokus pada kanker darah di Rambam Medical Center.

• Subspesialis transplantologi untuk kelainan darah
• Profesor akademik dengan keahlian tingkat penelitian
• Bekerja di pusat medis nasional terkemuka

Lebih dari 3.500 transplantasi sumsum tulang telah dilakukan – Dr. Stepensky diakui oleh Forbes sebagai salah satu dokter terbaik.

• 20 tahun praktik dengan spesialisasi hematologi pediatrik
• Ahli dalam mengobati anak-anak dengan kanker darah langka seperti limfoma Burkitt
• Praktik di Hadassah Medical Center di Israel
• Dikenal karena keahlian tingkat tinggi dan perawatan yang penuh kasih

Spesialis dalam onkohematologi, menangani kanker darah dan sistem limfatik di Assuta Medical Center.

• Fokus secara eksklusif pada keganasan hematologi seperti limfoma Burkitt
• Memberikan diagnosis ahli dan perencanaan perawatan untuk kanker darah yang kompleks
• Bekerja di dalam jaringan rumah sakit Assuta yang terkenal di Israel